Tekla Capital Management LLC Akebia Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$4.1 - $8.05 $877,162 - $1.72 Million
-213,942 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$5.39 - $9.15 $283,891 - $481,930
-52,670 Reduced 19.76%
213,942 $1.18 Million
Q2 2018

Aug 13, 2018
BUY
$9.15 - $11.34 $1.22 Million - $1.52 Million
133,763 Added 100.69%
266,612 $2.66 Million
Q1 2018

May 14, 2018
BUY
$9.53 - $15.68 $1.27 Million - $2.08 Million
132,849 New
132,849 $1.27 Million

Others Institutions Holding AKBA

# of Institutions
110
Shares Held
55.3M
Call Options Held
554K
Put Options Held
246K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $245M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email